See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

The i-port®

Davida Kruger and KK Patton

The i-port®

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

Metformin Archives

Diabetes and Metformin

Page 4
Danish Study Reports Three Diabetes Drugs Best for Lowering Cardiovascular Risk

A Danish study of 107,806 adults taking various diabetes medications has found that three drugs are the most effective at lowering the risk of cardiovascular disease and death: metformin, gliclazide (not marketed in the US), and repaglinide (Prandin). Other common diabetes medications, including glimepiride, glibenclamide (glyburide), glipizide, and tolbutamide, were linked to a higher risk of death both from all causes and from heart attack and stroke.  

Comments 1 comment - May 13, 2011 - * * * * *

Pre-Diabetes Glossary

This List defines terms that people with prediabetes commonly encounter as they learn more about the condition.

Comments 2 comments - Mar 29, 2011 - * * * * *

Kombiglyze Komes to a Pharmacy Near You

The kuriously named Kombiglyze XR, a combination of Onglyza (saxagliptin) and the old reliable metformin, has arrived at pharmacies and is available by prescription to people with type 2 diabetes. It's similar to Janumet, an older medication that's a combination of Januvia (sitagliptin) and metformin.

Comments 0 comments - Jan 25, 2011 - * * * * *

GLUMETZA: Extended Release Metformin

Depomed, Inc. and Santarus, Inc. announced new data suggesting that patients previously intolerant of metformin may be able to tolerate higher doses of metformin when treated with GLUMETZA® (metformin HCl extended release tablets).  The finding will be presented at the 70th Scientific Sessions of the American Diabetes Association (ADA) in Orlando. GLUMETZA is a once-daily, extended release formulation of metformin, and is approved for use in adults with type 2 diabetes mellitus. It is promoted in the U.S. by Santarus.

Comments 0 comments - Jul 1, 2010 - * * * * *

Metformin-Avandia Combo Slows Progression to Type 2 in Two-Thirds of At-Risk Patients

A Canadian study that tracked 207 patients suggests that a low-dose combination of metformin and Avandia can reduce the development of type 2 diabetes by 66 percent in people at high risk for the condition.

Comments 0 comments - Jun 15, 2010 - * * * * *

U.K. Study Links Metformin to B-12 Deficiency

If you take metformin to control your type 2 diabetes, ask your doctor to take a look at your vitamin B-12 levels when you get a chance. A recent British study shows that metformin may cause a deficiency in the vitamin, which is necessary for the regeneration of red blood cells and the maintenance of nervous system health.

Comments 0 comments - Jun 5, 2010 - * * * * *

Surprise! Metformin Works Differently Than Thought

CINCINNATI - The popular diabetes medication metformin works in different fashion than the current widely accepted view. This new finding could lead to wider use of the drug-particularly in people with cancer.

Comments 1 comment - May 4, 2010 - * * * * *

Starting Treatment Early Doubles Chance of Success for People with Diabetes

The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.

Comments 2 comments - Mar 12, 2010 - * * * * *

Insulin Used to Treat Diabetes May Be Linked to Increased Cancer Risk, Review Suggests

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

Comments 1 comment - Mar 5, 2010 - * * * * *

Does Something Smell Fishy? It Could Be Your Metformin

If you regularly take metformin, one of the oldest and most respected tools in doctors' anti-diabetes kits, chances are that you don't detect the unpleasant odor that turns some type 2s against the drug.  Some think it has fishy smell, while others say that it reminds them of the inside of an inner tube.

Comments 10 comments - Mar 4, 2010 - * * * * *

Next Page » « Previous Page
©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.